miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers

Pathol Res Pract. 2022 May:233:153886. doi: 10.1016/j.prp.2022.153886. Epub 2022 Apr 5.

Abstract

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide. HCC initiation, progression, and therapy failure are all influenced by various variables, including microRNAs (miRNAs). miRNAs are short non-coding RNA sequences that modulate target mRNA expression by deteriorating or repressing translation. miRNAs play an imperative role in HCC pathogenesis by triggering the induction of cancer stem cells (CSCs) and their proliferation, while also delaying apoptosis, sustaining the cell cycle, and inspiring angiogenesis, invasion, and metastasis. Additionally, miRNAs modulate crucial HCC-related molecular pathways such as the p53 pathway, the Wnt/β-catenin pathway, VEGFR2, and PTEN/PI3K/AKT pathway. Consequently, the goal of this review was to give an up-to-date overview of oncogenic and tumor suppressor (TS) miRNAs, as well as their potential significance in HCC pathogenesis and treatment responses, highlighting their underpinning molecular pathways in HCC initiation and progression. Similarly, the biological importance and clinical application of miRNAs in HCC are summarized.

Keywords: Drug Resistance; Hepatocellular carcinoma (HCC); Oncogenic miRNAs; Pathogenesis; Tumor Suppressor (TS) miRNAs.

Publication types

  • Review

MeSH terms

  • Carcinogenesis / genetics
  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Liver Neoplasms* / pathology
  • MicroRNAs* / genetics
  • Signal Transduction

Substances

  • MicroRNAs